Over 1.1 million total VOQUEZNA® prescriptions filled to date$57.6 million in Q4 net revenues; $175.1 million in FY 2025 net revenues, a 217% increase from FY 2024Q4 operating expenses of $55.9 ...

Adjusted EBITDA is defined as earnings before net interest expense, income taxes, depreciation, amortization and accretion expense, non-cash unit-based compensation expense, gains and losses on ...

CEO Michael S. Exton stated, "When we entered 2025, if you recall, we're still in the early days of our strategic pivot to being an R&D-focused company. And now in the second half of the year, I can ...

Coiante provided updated guidance: "We're lowering our operating expense projections for the year. Total operating expenses are now expected to be in the range of $105 million to $115 million from ...